US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 151.170
  • +2.730+1.84%
Close Mar 28 16:00 ET
  • 151.500
  • +0.330+0.22%
Post 16:55 ET
8.72BMarket Cap-16523P/E (TTM)

About Ascendis Pharma A/S Company

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.

Company Profile

SymbolASND
Company NameAscendis Pharma A/S
Listing Date01/28/2015
Issue Price18.00
Founded2006
CEOMr. Jan Moller Mikkelsen
MarketNASDAQ
Employees879
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressTuborg Boulevard 12
CityHellerup
ProvinceCapital Region
CountryDenmark
Zip Code2900
Phone45-70-22-22-44

Company Executives

  • Name
  • Position
  • Salary
  • Jan Moller Mikkelsen
  • President, Chief Executive Officer and Director
  • --
  • Michael Wolff Jensen
  • Executive Vice President and Chief Legal Officer
  • --
  • Lotte Sonderbjerg
  • Executive Vice President and Chief Administrative Officer
  • --
  • Scott T Smith
  • Executive Vice President and Chief Financial Officer
  • --
  • Camilla Harder Hartvig
  • Executive Vice President and Global Chief Commercial Officer
  • --
  • Peter Rasmussen
  • Vice President, Finance and Principal Accounting Officer
  • --
  • Flemming Steen Jensen
  • Executive Vice President, Product Supply and Quality
  • --
  • Dr. Kennett Sprogoe, PhD
  • Executive Vice President and Head of Innovation and Research
  • --
  • Dr. Stina Singel, M.D.
  • Executive Vice President and Head of Clinical Development, Oncology
  • --
  • Dr. Albert Cha, M.D.,PhD
  • Chairman of the Board
  • 84.91K
  • Lisa Bright
  • Independent Director
  • 56.90K
  • William Carl Fairey
  • Independent Director
  • --
  • Lars Holtug
  • Independent Director
  • 65.33K
  • Siham Imani
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg